Blood Test Helps Predict Survival From Advanced Prostate Cancer

A phase 3 clinical trial has shown that circulating tumor cell counts can predict which men are likely to respond to standard treatment and live longest and which might benefit from more aggressive new drug trials. CTCs are rare cancer cells that tumors shed in the blood. Read on to know more.